CEA-targeted vaccine (Etubics)

N/A

Report date: 2024/08/19 13:39:30

Base Information

Drug NameCEA-targeted vaccine (Etubics)
Drug Alias NameE2b-]-CEA vaccined5[E1-Ad5 [E1-D5 CEA vaccineE2B-]-CEA(6D) +[10] 
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsCarcinoembryonic antigen stimulants
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[19] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEtubics CorpNantkwest IncNantcell Inc +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Precision Biotechnology Co Ltd
Inactive CompaniesImmunitybio IncNational Cancer InstituteNantcell Inc
Active IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[7] 
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungThyroid Neoplasms +[12] 

Other Information

ATC CodeN/A
Related LinksN/A